ECG
15
2
2
8
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 15 trials
100.0%
+13.5% vs benchmark
7%
1 trials in Phase 3/4
13%
1 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (15)
The Effect of Simulation-Based ECG Training on ECG Reading Skills of Nursing Students
Effect of Nicotine Pouches on The Underlying Normal Electrocardiogram
Left Bundle Branch Area Pacing (LBBAP) Monitoring Assistant: Evaluation of Portable ECG Solution
Identifying Electrocardiographic Markers to Determine Eligibility for the Implantation of a Subcutaneous Defibrillator.
Validation of Perin Health Patch ECG Monitoring Device Performance and Placement Accuracy
AI-ECG Accessory Pathway Localisation Study
Hybrid Score to Predict OTVA-SOO in Patients with Wide Basal QRS
Further Study of AFGen1 Clinical Performance
Clinical Performance of AFGen1
Evaluation of CSF-3 in Performing ECG
Evaluating QTc, PK, Safety of Gemtuzumab Ozogamicin (GO) in Patients With CD33+ R/R AML
Smart Home Care of Cloud Base ECG on the Cardiotoxicity Prevention on the Cancer Patients.
AF Stroke Substudy SL-ECG Versus 12lead ECG
Evaluation Of The GE Monitor Product Line
Clinical Evaluation of the Vital Signs Monitoring System (VSMS)